Endocrinology | Physicians can more accurately classify patients at risk for type 1 diabetes with the help of a scoring system that improves identification between high-risk normoglycemic and low-risk dysglycemic individuals, according to research published in Diabetes Care. “The findings indicate that a reliance upon dysglycemia as a demarcation of risk in autoantibody-positive populations could result
PLAINSBORO, N.J. (PRWEB) April 09, 2014 -- Ironman triathlete Jay Hewitt will speak tomorrow at the evening reception of Patient-Centered Diabetes Care: Putting Theory into Practice, which is bringing leaders in diabetes healthcare delivery to the Princeton Marriott at Forrestal. On Friday, Dr. Robert Gabbay, chief medical officer of the Joslin Diabetes Center, will offer a keynote address.
MannKind Corp said the U.S. Food and Drug Administration extended the review date of its inhaled insulin treatment by three months, sending the company's shares down as much as 22 percent before the bell.
Listen up, Friends: it's officially crunch time to let the decision-makers at FDA know what we want to see in terms of accurate glucose meters and strips! Seriously, this is the first time in more than a decade that the regulatory agency's updated these rules on accuracy, and it's the first time in history the…
(Phys.org) —For next-generation smart devices, autonomy is key. These devices will be able to power themselves, independently respond to stimuli, and perform different kinds of work, all without human intervention. With these abilities, smart devices could potentially have very wide-reaching implications.
(April 8, 2014) – A federal jury ordered Eli Lilly and Co. and Takeda Pharmaceutical Co. to pay $9 billion after jurors said the companies hid the cancer risks of their Actos diabetes medicine. As part of the ruling, Indianapolis-based Lilly was
Scientific research into CGM-like sensors goes back more than 40 years. I was working with the first company to begin commercial development, MiniMed, back in 1992 when the science was really beginning to percolate. In 1999 the FDA approved the first CGM device for use in the United States.